BriaCell Historical Financial Ratios
| BCTXW Stock | USD 0.43 0.08 22.86% |
BriaCell Therapeutics is presently reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0, Invested Capital of 622.1 K or Average Payables of 749.9 K will help investors to properly organize and evaluate BriaCell Therapeutics financial condition quickly.
BriaCell |
About BriaCell Financial Ratios Analysis
BriaCell TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BriaCell Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BriaCell financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BriaCell Therapeutics history.
BriaCell Therapeutics Financial Ratios Chart
Add Fundamental
Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to BriaCell Therapeutics Corp. There are two different methods for calculating BriaCell Therapeutics invested capital: operating approach and financing approach. Understanding BriaCell Therapeutics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from BriaCell Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BriaCell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, BriaCell Therapeutics' ROIC is fairly stable compared to the past year. ROE is likely to climb to 5.08 in 2024, despite the fact that Book Value Per Share is likely to grow to (0.26).
| 2023 | 2024 (projected) | Net Current Asset Value | 402.0K | 357.4K | Days Payables Outstanding | 18.0K | 18.9K |
BriaCell Therapeutics fundamentals Correlations
Click cells to compare fundamentals
BriaCell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BriaCell Therapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (2.05) | 1.36 | 9.67 | (27.2) | (31.28) | (29.72) | |
| Book Value Per Share | (4.61) | 3.75 | 0.67 | (0.24) | (0.28) | (0.26) | |
| Free Cash Flow Yield | (0.35) | (0.17) | (0.0995) | (0.13) | (0.23) | (0.21) | |
| Operating Cash Flow Per Share | (1.62) | (0.51) | (0.81) | (1.52) | (1.37) | (1.44) | |
| Pb Ratio | (2.05) | 1.36 | 9.67 | (27.2) | (31.28) | (29.72) | |
| Free Cash Flow Per Share | (1.62) | (0.51) | (0.81) | (1.52) | (1.37) | (1.44) | |
| Inventory Turnover | 2.31 | 0.0942 | 0.0377 | 0.003613 | 0.003252 | 0.003414 | |
| Net Income Per Share | 1.94 | (0.19) | (0.75) | (1.3) | (1.17) | (1.23) | |
| Days Of Inventory On Hand | 157.68 | 3.9K | 9.7K | 101.0K | 90.9K | 95.5K | |
| Average Inventory | 4.0K | 103.6K | 357.6K | 2.8M | 2.6M | 2.7M | |
| Cash Per Share | 0.0273 | 3.75 | 2.65 | 1.36 | 1.56 | 1.49 | |
| Pocfratio | (5.83) | (10.05) | (8.0) | (4.33) | (4.98) | (5.23) | |
| Interest Coverage | 39.74 | 51.29 | 80.05 | (15.6K) | (18.0K) | (17.1K) | |
| Pfcf Ratio | (5.83) | (10.05) | (8.0) | (4.33) | (4.98) | (5.23) | |
| Days Payables Outstanding | 82.69 | 4.0K | 8.7K | 20.0K | 18.0K | 18.9K | |
| Income Quality | 0.31 | 18.09 | 0.47 | 1.17 | 4.89 | 5.14 | |
| Ev To Operating Cash Flow | (6.01) | (2.66) | (4.71) | (3.43) | 0.0357 | 0.0375 | |
| Pe Ratio | 4.88 | (26.89) | (8.62) | (5.06) | (4.56) | (4.78) | |
| Ev To Free Cash Flow | (6.01) | (2.66) | (4.71) | (3.43) | 0.0351 | 0.0368 | |
| Intangibles To Total Assets | 0.5 | 0.004231 | 0.00541 | 0.007918 | 0.034 | 0.0323 | |
| Net Debt To E B I T D A | (0.0428) | 3.27 | 1.21 | 0.78 | 0.9 | 0.85 | |
| Current Ratio | 0.066 | 103.81 | 45.0 | 14.96 | 0.49 | 0.47 | |
| Tangible Book Value Per Share | (4.95) | 3.73 | 0.65 | (0.26) | (0.29) | (0.28) | |
| Graham Number | 14.19 | 4.0 | 3.35 | 2.66 | 3.06 | 2.91 | |
| Shareholders Equity Per Share | (4.61) | 3.75 | 0.67 | (0.24) | (0.28) | (0.26) | |
| Graham Net Net | (5.12) | 3.72 | 0.57 | (0.4) | (0.47) | (0.44) | |
| Interest Debt Per Share | 0.56 | 0.36 | 0.004721 | 6.3E-5 | 5.7E-5 | 5.4E-5 | |
| Enterprise Value Over E B I T D A | (1.42) | (1.18) | (1.73) | (2.99) | (3.44) | (3.62) | |
| Roic | (0.48) | (0.0505) | (1.48) | 6.11 | 5.5 | 5.78 | |
| Payables Turnover | 4.41 | 0.0908 | 0.0418 | 0.0182 | 0.021 | 0.0199 | |
| Roe | (0.42) | (0.0506) | (1.12) | 5.38 | 4.84 | 5.08 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.